Impact of 10-Valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns Among Children Aged <5 Years and Adults With Human Immunodeficiency Virus Infection: Kenya, 2009–2013

BACKGROUND. Kenya introduced 10-valent pneumococcal conjugate vaccine (PCV10) among children <1 year in 2011 with catch-up vaccination among children 1–4 years in some areas. We assessed changes in pneumococcal carriage and antibiotic susceptibility patterns in children <5 years and adults. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Miwako, Bigogo, Godfrey, Kim, Lindsay, Mogeni, Ondari D., Conklin, Laura M., Odoyo, Arthur, Odiembo, Herine, Pimenta, Fabiana, Ouma, Dominic, Harris, Aaron M., Odero, Kennedy, Milucky, Jennifer L., Ouma, Alice, Aol, George, Audi, Allan, Onyango, Clayton, Cosmas, Leonard, Jagero, Geofrey, Farrar, Jennifer L., da Gloria Carvalho, Maria, Whitney, Cynthia G., Breiman, Robert F., Lessa, Fernanda C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942635/
https://www.ncbi.nlm.nih.gov/pubmed/30959526
http://dx.doi.org/10.1093/cid/ciz285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942635/
https://www.ncbi.nlm.nih.gov/pubmed/30959526
http://dx.doi.org/10.1093/cid/ciz285

Ejemplares similares